반응식
[CH3:1][CH:2]1[O:7][CH:6]([O:8][C:9]2[C:18](=[O:19])[C:17]3[C:12](=[CH:13][C:14]([OH:21])=[CH:15][C:16]=3[OH:20])[O:11][C:10]=2[C:22]2[CH:27]=[C:26]([OH:28])[C:25]([OH:29])=[C:24]([OH:30])[CH:23]=2)[CH:5]([OH:31])[CH:4]([OH:32])[CH:3]1[OH:33].[OH-].[Na+].[Ag:36]>C1(C)C=CC(S([O-])(=O)=O)=CC=1.[Ag+].O>[CH3:1][CH:2]1[O:7][CH:6]([O:8][C:9]2[C:18](=[O:19])[C:17]3[C:12](=[CH:13][C:14]([OH:21])=[CH:15][C:16]=3[OH:20])[O:11][C:10]=2[C:22]2[CH:23]=[C:24]([OH:30])[C:25]([OH:29])=[C:26]([OH:28])[CH:27]=2)[CH:5]([OH:31])[CH:4]([OH:32])[CH:3]1[OH:33].[Ag:36]참가 물질
6
실험 절차
Myricetin 3-rhamnoside/silver colloidal nanoparticle catalyst is prepared by dissolving 1.04 g myricetin 3-rhamnoside in a beaker containing 750 ml DI water at room temperature. With stirring, 1 N NaOH solution is added to adjust the solution pH to 11. In a separate beaker, 1.4 g silver p-toluenesulfonate is dissolved in 40 mL DI water. The silver ion solution is added to the myricetin 3-rhamnoside solution with vigorous stirring. The molar ratio of silver to myricetin 3-rhamnoside is 1:0.4. The beaker containing the aqueous catalyst solution is placed in a 50° C. water bath for 12 hours to test its stability. After 12 hours the solution is observed and no precipitate is expected indicating that the catalyst is still stable.
후처리
- additionThe beaker containing the aqueous catalyst solution
- customis placed in a 50° C.
- customfor 12 hours
출처 및 근거
- ORD 기록
- ord-1b7f6a3bd0b240de9ea28178bd7440f4
- 출처 데이터셋
- uspto-grants-2016_09
- 특허 번호
- US09441300B2
연결된 노트
불러오는 중…